| Alexis C Weil, MD | |
|
325 9th Ave, Seattle, WA 98104-2420 | |
| (206) 731-3000 | |
| Not Available |
| Full Name | Alexis C Weil |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 325 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164550091 | NPI | - | NPPES |
| 8356552 | Medicaid | WA | |
| 110248144 | Other | WA | RAIL ROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD00038996 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The Food and Drug Administration and European regulators said they were taking action on Avandia, made by GlaxoSmithKline PLC, because of data tying it to increased risk of heart attacks.
IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."
The incarcerated population - both those currently in prison and those who have been released - are more susceptible to heart disease than the rest of the country's population. And what we know about the factors that play into this is extremely limited, according to researchers.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced the closing of a registered direct placement (Placement) with $2.6 million received from the offering.
The FK506-binding protein 51 (FKBP51) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the very similar functional counterplayer FKBP52.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexis C Weil, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Alexis C Weil, MD 325 9th Ave, Seattle, WA 98104-2420 Ph: (206) 731-3000 |
News Archive
The Food and Drug Administration and European regulators said they were taking action on Avandia, made by GlaxoSmithKline PLC, because of data tying it to increased risk of heart attacks.
IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."
The incarcerated population - both those currently in prison and those who have been released - are more susceptible to heart disease than the rest of the country's population. And what we know about the factors that play into this is extremely limited, according to researchers.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced the closing of a registered direct placement (Placement) with $2.6 million received from the offering.
The FK506-binding protein 51 (FKBP51) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the very similar functional counterplayer FKBP52.
› Verified 4 days ago
Dr. Tinsley Coble, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1550 N 115th Street, Northwest Hospital, Seattle, WA 98133 Phone: 206-368-1849 | |
Philip W Royal, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 | |
Yordanos T Kahsai, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-624-1144 | |
Dr. James Papathanasiou, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 Broadway, Seattle, WA 98122 Phone: 206-329-1760 | |
Kristin T Tang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 747 Broadway, Seattle, WA 98122 Phone: 206-386-6000 Fax: 206-215-6364 | |
Srirama Josyula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
David J Horne, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-3241 |